1,2-dimethylhydrazine decreases expression ISO RGD:1323268 6480464 1, 2-Dimethylhydrazine results in decreased expression of RHOBTB3 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:1323267 6480464 Estradiol affects the expression of RHOBTB3 mRNA CTD PMID:14699072 17beta-estradiol decreases expression ISO RGD:1323267 6480464 Estradiol results in decreased expression of RHOBTB3 mRNA CTD PMID:21185374 17beta-estradiol increases expression ISO RGD:1323267 6480464 Estradiol results in increased expression of RHOBTB3 mRNA CTD PMID:24758408 17beta-estradiol multiple interactions ISO RGD:1323267 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RHOBTB3 mRNA, EGF protein inhibits the reaction [Estradiol results in increased expression of RHOBTB3 mRNA] CTD PMID:20823114 , PMID:24758408 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1323267 6480464 Dihydrotestosterone results in increased expression of RHOBTB3 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1323268 6480464 Tetrachlorodibenzodioxin results in decreased expression of RHOBTB3 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RHOBTB3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RHOBTB3 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1323267 6480464 Tetrachlorodibenzodioxin results in decreased expression of RHOBTB3 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323268 6480464 Tetrachlorodibenzodioxin affects the expression of RHOBTB3 mRNA CTD PMID:21570461 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1323268 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of RHOBTB3 mRNA CTD PMID:18648102 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:1323267 6480464 Am 580 results in increased expression of RHOBTB3 mRNA CTD PMID:16982809 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RHOBTB3 mRNA CTD PMID:24780913 aflatoxin B1 decreases methylation ISO RGD:1323267 6480464 Aflatoxin B1 results in decreased methylation of RHOBTB3 gene CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1323267 6480464 Aflatoxin B1 results in increased methylation of RHOBTB3 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1323267 6480464 Tretinoin results in increased expression of RHOBTB3 mRNA CTD PMID:21934132 aristolochic acid decreases expression ISO RGD:1323267 6480464 aristolochic acid I results in decreased expression of RHOBTB3 mRNA CTD PMID:33212167 arsane increases response to substance ISO RGD:1323267 6480464 RHOBTB3 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 arsenic atom increases response to substance ISO RGD:1323267 6480464 RHOBTB3 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA CTD PMID:33854195 benzo[a]pyrene increases mutagenesis ISO RGD:1323267 6480464 Benzo(a)pyrene results in increased mutagenesis of RHOBTB3 gene CTD PMID:25435355 benzo[a]pyrene affects methylation ISO RGD:1323267 6480464 Benzo(a)pyrene affects the methylation of RHOBTB3 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1323267 6480464 Benzo(a)pyrene results in increased methylation of RHOBTB3 3' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1323267 6480464 7 more ... CTD PMID:20018196 bilirubin IXalpha decreases expression ISO RGD:1323267 6480464 Bilirubin results in decreased expression of RHOBTB3 mRNA CTD PMID:20196124 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of RHOBTB3 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RHOBTB3 mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO RGD:1323267 6480464 bisphenol A results in increased expression of RHOBTB3 mRNA CTD PMID:29275510 bucladesine multiple interactions ISO RGD:1323267 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RHOBTB3 mRNA CTD PMID:20823114 cadmium dichloride increases expression ISO RGD:1323267 6480464 Cadmium Chloride results in increased expression of RHOBTB3 mRNA CTD PMID:26472689 carbamazepine affects expression ISO RGD:1323267 6480464 Carbamazepine affects the expression of RHOBTB3 mRNA CTD PMID:25979313 carmustine affects response to substance ISO RGD:1323267 6480464 RHOBTB3 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 CGP 52608 multiple interactions ISO RGD:1323267 6480464 CGP 52608 promotes the reaction [RORA protein binds to RHOBTB3 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1323268 6480464 Chlordecone results in increased expression of RHOBTB3 mRNA CTD PMID:33711761 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA CTD PMID:33854195 cisplatin increases expression ISO RGD:1323267 6480464 Cisplatin results in increased expression of RHOBTB3 mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:1323267 6480464 Cisplatin results in decreased expression of RHOBTB3 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1323267 6480464 cobaltous chloride results in decreased expression of RHOBTB3 mRNA CTD PMID:19320972 , PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of RHOBTB3 mRNA CTD PMID:24386269 copper(II) sulfate decreases expression ISO RGD:1323267 6480464 Copper Sulfate results in decreased expression of RHOBTB3 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1323267 6480464 Cyclosporine results in decreased expression of RHOBTB3 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone increases expression ISO RGD:1323267 6480464 Dexamethasone results in increased expression of RHOBTB3 mRNA CTD PMID:12782123 , PMID:25047013 dibutyl phthalate increases expression ISO RGD:1323268 6480464 Dibutyl Phthalate results in increased expression of RHOBTB3 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1323267 6480464 Doxorubicin affects the expression of RHOBTB3 mRNA CTD PMID:29803840 elemental selenium multiple interactions ISO RGD:1323267 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB3 mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:1323267 6480464 Selenium results in decreased expression of RHOBTB3 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of RHOBTB3 mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:1323268 6480464 Ethanol results in increased expression of RHOBTB3 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1323268 6480464 Ethanol affects the splicing of RHOBTB3 mRNA CTD PMID:30319688 folic acid decreases expression ISO RGD:1323268 6480464 Folic Acid results in decreased expression of RHOBTB3 mRNA CTD PMID:25629700 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of RHOBTB3 mRNA CTD PMID:33387578 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA CTD PMID:33854195 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA CTD PMID:33854195 isotretinoin increases expression ISO RGD:1323267 6480464 Isotretinoin results in increased expression of RHOBTB3 mRNA CTD PMID:20436886 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of RHOBTB3 mRNA CTD PMID:24136188 medroxyprogesterone acetate multiple interactions ISO RGD:1323267 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RHOBTB3 mRNA CTD PMID:20823114 mercury dibromide increases expression ISO RGD:1323267 6480464 mercuric bromide results in increased expression of RHOBTB3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA CTD PMID:27188386 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of RHOBTB3 mRNA CTD PMID:30467583 methyl methanesulfonate decreases expression ISO RGD:1323267 6480464 Methyl Methanesulfonate results in decreased expression of RHOBTB3 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1323267 6480464 methylmercuric chloride results in increased expression of RHOBTB3 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA CTD PMID:27188386 nickel atom decreases expression ISO RGD:1323267 6480464 Nickel results in decreased expression of RHOBTB3 mRNA CTD PMID:24768652 , PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RHOBTB3 mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1323267 6480464 panobinostat results in increased expression of RHOBTB3 mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:1323267 6480464 Acetaminophen results in decreased expression of RHOBTB3 mRNA CTD PMID:21420995 phenobarbital affects expression ISO RGD:1323267 6480464 Phenobarbital affects the expression of RHOBTB3 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1323267 6480464 Phenylmercuric Acetate results in increased expression of RHOBTB3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO RGD:1323267 6480464 potassium chromate(VI) results in decreased expression of RHOBTB3 mRNA CTD PMID:22714537 quercetin decreases expression ISO RGD:1323267 6480464 Quercetin results in decreased expression of RHOBTB3 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:1323267 6480464 [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of RHOBTB3 mRNA CTD PMID:19059307 raloxifene affects expression ISO RGD:1323267 6480464 Raloxifene Hydrochloride affects the expression of RHOBTB3 mRNA CTD PMID:14699072 SB 431542 multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1323267 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB3 mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:1323267 6480464 Selenium results in decreased expression of RHOBTB3 mRNA CTD PMID:19244175 sunitinib increases expression ISO RGD:1323267 6480464 Sunitinib results in increased expression of RHOBTB3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1323267 6480464 Tamoxifen affects the expression of RHOBTB3 mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO RGD:1323267 6480464 [Tamoxifen co-treated with ESR1 protein] results in increased expression of RHOBTB3 mRNA CTD PMID:19059307 temozolomide affects response to substance ISO RGD:1323267 6480464 RHOBTB3 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 testosterone enanthate affects expression ISO RGD:1323267 6480464 testosterone enanthate affects the expression of RHOBTB3 mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO RGD:1323268 6480464 Carbon Tetrachloride affects the expression of RHOBTB3 mRNA CTD PMID:17484886 thapsigargin decreases expression ISO RGD:1323268 6480464 Thapsigargin results in decreased expression of RHOBTB3 protein CTD PMID:24648495 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA CTD PMID:33854195 thimerosal decreases expression ISO RGD:1323267 6480464 Thimerosal results in decreased expression of RHOBTB3 mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of RHOBTB3 mRNA CTD PMID:34492290 topotecan increases expression EXP 6480464 Topotecan results in increased expression of RHOBTB3 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of RHOBTB3 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of RHOBTB3 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1323267 6480464 trichostatin A results in decreased expression of RHOBTB3 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:1323267 6480464 trichostatin A results in increased expression of RHOBTB3 mRNA CTD PMID:24935251 , PMID:26272509 triclosan decreases expression ISO RGD:1323267 6480464 Triclosan results in decreased expression of RHOBTB3 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1323268 6480464 trimellitic anhydride results in decreased expression of RHOBTB3 mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of RHOBTB3 mRNA CTD PMID:30589522 urethane decreases expression ISO RGD:1323267 6480464 Urethane results in decreased expression of RHOBTB3 mRNA CTD PMID:28818685 ursodeoxycholic acid affects expression ISO RGD:1323267 6480464 Ursodeoxycholic Acid affects the expression of RHOBTB3 mRNA CTD PMID:18422935 valproic acid affects expression ISO RGD:1323268 6480464 Valproic Acid affects the expression of RHOBTB3 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1323267 6480464 Valproic Acid results in increased expression of RHOBTB3 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1323267 6480464 Valproic Acid affects the expression of RHOBTB3 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:1323268 6480464 Vancomycin results in decreased expression of RHOBTB3 mRNA CTD PMID:18930951 vitamin E multiple interactions ISO RGD:1323267 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB3 mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1323267 6480464 Vitamin E results in decreased expression of RHOBTB3 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:1323267 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOBTB3 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1323267 6480464 vorinostat results in increased expression of RHOBTB3 mRNA CTD PMID:26272509 vorinostat decreases expression ISO RGD:1323267 6480464 vorinostat results in decreased expression of RHOBTB3 mRNA CTD PMID:27188386 zoledronic acid decreases expression ISO RGD:1323267 6480464 zoledronic acid results in decreased expression of RHOBTB3 mRNA CTD PMID:24714768
